The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Platelet Function Predicts Myocardial Damage in Patients With Acute Myocardial Infarction
Abstract
Background— Platelet activation is a hallmark of acute coronary syndromes. Numerous lines of evidence suggest a mechanistic link between von Willebrand factor or platelet hyperfunction and myocardial damage in patients with acute coronary syndromes. Thus, we assessed whether platelet function under high shear rates (collagen adenosine diphosphate closure times [CADP-CTs]) measured with the platelet function analyzer (PFA-100) may be enhanced in patients with myocardial infarction (MI) and whether it may predict the extent of myocardial damage as measured by creatine kinase (CK-MB) or troponin T (TnT) levels. Methods and Results— Patients with acute chest pain or symptoms suggestive of acute coronary syndromes (n=216) were prospectively examined at an emergency department. CADP-CT was significantly shorter in patients with MI, particularly in those with an ST-segment-elevation MI (STEMI) compared with the other patient groups (unstable angina, stable coronary artery disease, or controls). Furthermore, CADP-CT and collagen epinephrine–CT at presentation were independent predictors of myocardial damage as measured by CK-MB or TnT. Patients with MI whose CADP-CT values fell in the first quartile had 3-fold higher CK-MB and TnT levels than those in the fourth quartile. Conclusions— Patients with STEMI have significantly enhanced platelet function when measured under high shear rates. CADP-CT is an independent predictor of the severity of MI, as measured by markers of cardiac necrosis. Measurement of platelet function with the PFA-100 may help in the risk stratification of patients presenting with MI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“enhanced platelet reactivity is associated with both the extent of end organ injury and adverse prognosis (Frossard et al., 2004; Tantry et al., 2013).”
From Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk (2016) · cites this paper as Frossard et al., 2004
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E., Green, L. A., Hand, M. M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., Lamas, G. A., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,348
Antman, E. M., Bassand, J., Klein, W. W., Ohman, M. E., Sendón, J. L. L., Rydén, L., Simoons, M. L., & Tendera, M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00804-4 · Cited by 4,824
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D. J., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,475
Thompson, S. G., Kienast, J., Pyke, S., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,819
Prognostic Value of Myeloperoxidase in Patients with Chest Pain
Brennan, M., Penn, M. S., Lente, F. V., Nambi, V., Shishehbor, M. H., Aviles, R. J., Goormastic, M., Pepoy, M. L., McErlean, E. S., Topol, E. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035003 · Cited by 1,071
D, E. B. M., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D. J., Kupersmith, J., Levin, T. N., et al. (2002) · Circulation · doi:10.1161/01.cir.0000037106.76139.53 · Cited by 844
Ryan, T. J., Antman, E. M., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., Riegel, B. J., Russell, R. O., Smith, E. E., et al. (1999) · Circulation · doi:10.1161/01.cir.100.9.1016 · Cited by 742
Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina
Aukrust, P., Müller, F., Ueland, T., Berget, T., Aaser, E., Brunsvig, A., Solum, N. O., Forfang, K., Frøland, S. S., & Gullestad, L. L. (1999) · Circulation · doi:10.1161/01.cir.100.6.614 · Cited by 506
von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?
Lip, G. Y. H. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00039-4 · Cited by 457
Roffi, M., Chew, D. P., Mukherjee, D., Bhatt, D. L., White, J. A., Heeschen, C., Hamm, C. W., Moliterno, D. J., Califf, R. M., White, H. D., et al. (2001) · Circulation · doi:10.1161/hc4801.100029 · Cited by 427
Research works printed but not linked: 12
- 10.1161/circ.100.6.614 · DOI
- 10.1161/circ.94.6.1239 · DOI
- 10.1161/circ.100.20.2045 · DOI
- 10.1161/circ.104.23.2767 · DOI
- 10.1182/blood.V65.4.823.823 · DOI
- 10.1161/circ.99.5.608 · DOI
- 10.1161/circ.100.9.1016 · DOI
- 2000, Br J Haematol, 111, 733
- 10.1161/circ.102.19.2329 · DOI
- 10.1161/circ.101.13.1619 · DOI
- 2003, J Thromb Haemost, 1, OC328.
- 2002, Rev Cardiovasc Med, 3, S13
Cited by
Sorted by citations
Items 201–253 of 253
Characteristics of new P2Y12 inhibitors
Golino, P. (2013) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328364bb18 · Cited by 4
Antithrombotic treatment in primary percutaneous coronary intervention
Voll, F., Kuna, C., Ndrepepa, G., Kastrati, A., & Cassese, S. (2021) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2021.1902807 · Cited by 4
Pearson, C., Przyklenk, K., Mika, V. H., Ayaz, S. I., Ellis, M. M., Varade, P., Tolomello, R., & Welch, R. D. (2016) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2016.11.036 · Cited by 4
Tommasino, A., Fiorentini, V., Mattaroccia, G., Scoccia, A., & Barbato, E. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2511416 · Cited by 3
Guo, C., Zhao, J., Chen, M., Zhang, Y., Wu, R., Li, Q., Zhao, H., & Wei, J. J. (2021) · Platelets · doi:10.1080/09537104.2021.1974370 · Cited by 3
Qiu, X., Li, X., Fu, K., Chen, W., & Chen, W. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289243 · Cited by 3
Vakili, H., Khaheshi, I., Sharifi, A., Nickdoost, N., Namazi, M. H., Safi, M., Saadat, H., Parsa, S. A., Akbarzadeh, M. A., Naderian, M., et al. (2020) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x20666200206123118 · Cited by 3
Le concept de « résistance » à l’aspirine : mécanismes et pertinence clinique
Reny, J., Bonvini, R. F., Barazer, I., Berdagué, P., de Moerloose, P., Schved, J., Gris, J., & Fontana, P. (2009) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.02.028 · Cited by 3
Acetylsalicylic acid decreases clotting in combination with enoxaparin during haemodialysisin vitro
Samaha, E., Schwameis, M., Schranz, S., Watschinger, B., Buchmüller, A., & Jilma, B. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy229 · Cited by 3
Self-citationContinuous Positive Airway Pressure and Platelet Activation in Obstructive Sleep Apnoea
Cox, D. M., & Bradford, A. (2008) · Respiration · doi:10.1159/000164392 · Cited by 3
Blachier, F. (2023) · Springer eBooks · doi:10.1007/978-3-031-26322-4_5 · Cited by 2
Clinical Significance of Baseline Platelet Reactivity in Patients With Acute Coronary Syndrome
Sedky, H. A., Elsewefy, D. A., Saad, A. A., Ahmed, M. I., & El-Maraghy, H. M. (2012) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612439341 · Cited by 2
Kılıç, A., & Kurtul, A. (2017) · Angiology · doi:10.1177/0003319717724274 · Cited by 2
RetractedPatti, G., & Nusca, A. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0806 · Cited by 2
Hombach, V. (2009) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-009-0058-z · Cited by 1
Bimodal response to aspirin loading in acute ST-elevation myocardial infarction
Fefer, P., Beigel, R., Varon, D., Shenkman, B., Shechter, M., Savion, N., Hod, H., & Matetzky, S. (2012) · Platelets · doi:10.3109/09537104.2012.724738 · Cited by 1
Hof, A. W. J. V. ’. (2010) · European Heart Journal Supplements · doi:10.1093/eurheartj/suq022 · Cited by 1
Duszyńska, M., & María, J. L.-C. (2013) · Biblioteka Uniwersytetu Medycznego w Poznaniu · Cited by 1
Kobat, M. A., Balın, M., Çelik, A., Baydaş, A., & Dağlı, M. N. (2014) · Journal of Investigative Medicine · doi:10.2310/jim.0000000000000013 · Cited by 1
Microparticles: Surrogate Markers and Promoters of Cardiovascular Diseases
Moser, M., & Diehl, P. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-66224-4_8 · Cited by 1
The Role of Immune Cell Types in Ischemic Heart Disease Progression: A Systematic Review
Liu, J. X., Moosa, V. A., & Tan, I. M. (2021) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.311 · Cited by 1
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
Ma, R., Zhang, Q., Liu, Y., Li, H., Chen, H., Zhang, Q., Qiao, J., Qi, K., Shen, G., Sun, C., et al. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01477-y · Cited by 1
[High platelet reactivity during reperfusion - a new risk factor of no reflow?].
Koziński, M., & Kubica, J. (2012) · PubMed · Cited by 1
Markers of Autolysis in Acute ST Elevation Myocardial Infarction – A Comparative Analysis
Maharjan, P., Manandhar, R., Xu, W., Ma, S., Han, W., Liu, Y., Zhou, Y., Wu, Y., Sun, C., & Yuan, Z. (2015) · Journal of Nepal Medical Association · doi:10.31729/jnma.2769 · Cited by 1
Does glycoprotein IIB/IIIA resistance exist?
Smit, J. J. J., & Hof, A. W. J. V. ’. (2007) · Netherlands Heart Journal · doi:10.1007/bf03086016 · Cited by 1
Volpi, E., Gianetti, J., & Clerico, A. (2006) · CINECA IRIS Institutional Research Information System (Sant'Anna School of Advanced Studies) · Cited by 1
Chien, K.-W., Wu, H., Chang, Y.-J., Lee, M.-H., Chang, C.-F., & Chou, C.-C. (2006) · Zhōnghuá mínguó jízhěn yīxuéhuì yīzhì
Manandhar, R., & Sun, C. (2015) · Nepalese Heart Journal · doi:10.3126/njh.v12i2.13385
Kerényi, A., Soltész, P., Veres, K., Szegedi, G., & Muszbek, L. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.10.003
Orrego, C. N., Camayoc, A. D. A., & Marín, J. A. D. (2011) · Revista Peruana de Epidemiología
Gómez, M. L., Silvestre, M. M., & Botella, F. G. (2009)
Nykl, R., Plášek, J., Fürst, T., Fürstová, J., Gumulec, J., Lichá, K., & Homza, M. (2015) · Cor et Vasa · doi:10.1016/j.crvasa.2015.11.004
Cardiovascular Biology and Cell Signalling
Grove, E. L., Hvas, A., & Kristensen, S. D. (2009)
Gómez, M. L., Silvestre, M. M., & Botella, F. G. (2009)
Genetic influences on platelet function in coronary artery disease and myocardial infarction
Douglas, H. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Inhibitors of Platelet Adhesion: VWF-GP1b/IX and Collagen-GPVI Inhibitors
Schaub, R. G. (2009) · Fundamental and clinical cardiology · doi:10.3109/9781420069242.026
Personalised Medicine in New Zealand: A new approach to healthcare delivery
Gladding, P. A. (2011) · ResearchSpace (University of Auckland)
Acetylsalycylic Acid Resistance and Risk Factors in Acute Ischemic Stroke Patients
Arslan, Y., Yoldaş, T. K., Zorlu, Y., & Sipahi, H. (2015) · Turkish Journal of Cerebrovascular Diseases · doi:10.5505/tbdhd.2015.41736
Kopytsya, M. P., Kutya, I., Hіlova, J. V., Rodionova, J. V., & Peteneva, L. (2020) · Ukrainian Therapeutical Journal · doi:10.30978/utj2020-4-16
Giannakopoulou, N. (2021) · Journal of Hematology and Blood Disorders · doi:10.15744/2455-7641.7.103
(2007) · Acute Cardiac Care · doi:10.1080/17482940701649731
Ma, R., Liu, Y., Zhang, Q., Chen, H., Zhang, Q., Guo, W., Qiao, J., Qi, K., Shen, G., Sun, C., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2487838/v1
Mahmoud, M. R., Aljibreen, A. F., Marzouq, S. T., Alshammari, Abdelaziz, S. G., Abdelaziz, O. G., Balouch, F. K. Z., & Abbas, A. F. A. (2023) · Medical Science · doi:10.54905/disssi/v27i136/e270ms3046
Fathelbab, H. T., Abdelghany, M., Rizk, A., & Shawky, M. A. (2024) · The Egyptian Journal of Critical Care Medicine · doi:10.1007/s44349-024-00003-z
Ho, H.-J., Wu, L.-C., & Chen, Y. (2024) · Diagnostics · doi:10.3390/diagnostics14242848
Nitric Oxide-Releasing or Enhancing Agents
Gresele, P., Momi, S., & Guglielmini, G. (2025) · Springer eBooks · doi:10.1007/978-3-031-96360-5_6
Tarasova, L. V. T., Алексеевна, К. К., & Tsyganova, Y. V. (2026) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-244-12-127-134
Roule, V., Stettler, R., Blanchart, K., Lacôte, C., Bignon, M., Lemaître, A., Schwob, L., Parienti, J., Peron, C., Briet, C., et al. (2026) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-026-03258-8
Metadata
- Authors
- Frossard, M., Fuchs, I., Leitner, J. M., Hsieh, K., Vlcek, M., Losert, H., Domanovits, H., Schreiber, W., Laggner, A. N., & Jilma, B.
- Affiliations
- University of Vienna (AT)
- Venue
- Circulation
- Published
- 2004-09-14
- Volume
- 110
- Issue
- 11
- Pages
- 1392-1397
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2156637699
- Cited by
- 254
- References
- 36
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 10 · 2023: 6 · 2022: 5 · 2021: 9 · 2020: 10 · 2019: 7 · 2018: 3 · 2017: 6 · 2016: 8 · 2015: 7 · 2014: 6 · 2013: 10 · 2012: 19
- FWCI
- 13.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Keywords
- platelet function, acute myocardial infarction, ST-elevation myocardial infarction, platelet function analyzer, high shear rate, von Willebrand factor, platelet hyperreactivity, myocardial injury, creatine kinase-MB, troponin T, risk stratification, acute coronary syndrome
- MeSH terms
- Clopidogrel, Abciximab, Tirofiban, Eptifibatide, Adenosine Diphosphate, Aged, Antibodies, Monoclonal, Anticoagulants, Aspirin, Cardiovascular Agents, Collagen, Female, Humans, Immunoglobulin Fab Fragments, Leukocyte Count, Male, Middle Aged, Myocardial Infarction, Myocardium, Necrosis, Peptides, Platelet Aggregation Inhibitors, Platelet Function Tests, Predictive Value of Tests, Prospective Studies, Ticlopidine, Tyrosine, von Willebrand Factor, Platelet Activation, Comorbidity, Myocardial Ischemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
